title: Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?
authors.affiliation: Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: Bo
authors.initials: B
authors.lastname: Shen
authors.forename: Edy E
authors.initials: EE
authors.lastname: Soffer
mesh_terms: D002243:Carbolines / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000145:classification / Q000188:drug therapy*; D000075202:Contraindications; D003967:Diarrhea / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D010353:Patient Education as Topic
chemical_list: D002243:Carbolines; D005765:Gastrointestinal Agents; C090840:alosetron